Search Our Blog

 Subscribe to Our Blog!

Innovative Ideas for Global Patient Recruitment

Current Articles | RSS Feed RSS Feed

Google X Searches for What it Means to be Healthy

  
  
  
photo by bgr.com

Prevention vs. Treatment
Google’s semi-secret and futuristic research lab, Google X, is busy working on something new – the Baseline Study. The idea is to define what it means to be “healthy” so that one day, this health baseline might help us better detect certain health risks and identify changes relating to serious, more debilitating diseases before they worsen. 

Led by renowned molecular biologist Andrew Conrad, in partnership with Duke and Stanford universities, the project will develop wearable technology to collect data and measurements from 175 people – a number that may increase to thousands of healthy participants with a duration of up to 10 years or longer. For example, participants may wear Google’s smart contact lenses to monitor glucose levels. Once the data is collected, Google will analyze the information and look for any patterns, also called “biomarkers,” to hopefully catalog and spot predictable patterns in diseases or irregularities.


BBK Worldwide Honored in Best Mobile App Category by Ragan Awards 2014

  
  
  
Mobile App

We are excited to announce our recent Honorable Mention for My Clinical Study BuddySM in the “Best Mobile App” category of the 2014 Ragan’s Health Care PR and Marketing Awards! Designed to integrate into study participants’ daily lives, My Clinical Study BuddySM is a key competitive differentiator in today’s increasingly shifting and ever-changing clinical landscape. Underscoring its adaptive model, the mobile app utilizes a technology-based solution that can change in real-time and adjust to sponsor’s needs in order to help reduce overall trial costs and maximize patient engagement.

Managing Social Media Chatter in Clinical Research: Shire Weighs In

  
  
  
Elizabeth Mascherino, Assoc. Director of Patient Recruitment and Engagement at Shire


Utilizing social media in clinical research is a hot topic in the clinical R&D industry and many pharmaceutical companies are rightfully beginning to take note. According to a survey by the Pew Research Center, 85% of U.S. adults use the internet and 72% of those users say they have looked online for health information within the past year; however, The Tufts Center for the Study of Drug Development reports that only approximately 10% of trials reportedly use social media to recruit patients. Furthermore, BBK Worldwide research shows that pharmaceutical sponsors who use social media in their clinical trials are gaining a strong competitive advantage in terms of patient recruitment and retention.

Today we’re featuring a guest blog post from our friend, Elizabeth Mascherino. Elizabeth is Associate Director of Patient Recruitment and Engagement at Shire where her goal is to enable clinical operations to set realistically aggressive enrollment goals during study planning, and then help them achieve those goals through smart, data driven patient engagement strategies. As an expert on patient recruitment and social media strategies in clinical research, we knew we had to ask Elizabeth to provide her perspective on how Shire and other pharmaceutical companies can manage and benefit from social media chatter as it relates to clinical research. Here’s what she had to say:


BBK Worldwide Head of Social Strategy, Aaron Fleishman, Named to PharmaVOICE 100

  
  
  
aaron resized 600BBK is very proud to annouce that our very own Aaron Fleishman has been named to PharmaVOICE Magazine’s annual list of the 100 most inspiring people in life sciences! The award recognizes Aaron’s contributions in helping elevate patient volunteers in research so that their voices are heard.

As an industry leader, Aaron’s innovative strategies and efforts have resulted in the development of new educational and interactive resources to help improve the overall study participation experience while ensuring that patients and caregivers remain at the center of every campaign. “His passion for the industry and his patient-centric approach are an inspiration – for his colleagues, and our clients and partners,” said Joan F. Bachenheimer, BBK founding prinicipal.

FDA Releases New Draft Guidance on the Informed Consent Process

  
  
  
describe the image

This past July 15th, the FDA tilted its regulator hat and announced the release of a new Draft Guidance, Informed Consent Information Sheet, to help clinical investigators and sponsors involved in clinical trials obtain informed consent from subjects.  The new Draft Guidance provides important updates to the FDA’s informed consent policies and covers the specific responsibilities of IRBs, clinical investigators, and sponsors regarding informed consent.  

Adaptive Patient Recruitment: A New Specialty in Clinical Trial Marketing

  
  
  
describe the image

Last month, at the DIA's Annual Meeting in San Diego, we launched Adaptive Patient Recruitment, a new specialty in clinical trial marketing that helps solve today's unique challenges around global enrollment. Through a custom and balanced mix of cutting-edge technology, data-driven consultation, and strategic branding and advertising, our Adaptive Patient Recruitment discipline allows today's global study community to work more collaboratively, respond rapidly to often unforeseen enrollment challenges, and make more informed decisions at critical study milestones.

Stuart Scott Bravely Shares Clinical Trial Experience at ESPYS

  
  
  
dm 140716 Stuart Scott Accepts Jimmy V Award default resized 600

There wasn't a dry eye in the audience last night when the acclaimed ESPN veteran Stuart Scott accepted his Jimmy V Perseverance Award at the 2014 ESPYS last night. The longtime SportsCenter personality opened up about his seven-year battle with appendiceal cancer – in which he has endured fifty-eight chemotherapy infusions, three abdomen surgeries and countless treatments as he continues to fight the disease.

Three Challenges to Implementing Social Media Into Your Patient Recruitment Campaign

  
  
  
FG online Main 1 large resized 600

Considering a social media campaign for your clinical trial? While there are proven advantages to using social media as a patient recruitment tactic, additional considerations must be explored when deciding if social media fits your campaign’s needs. First, scope out your audience by evaluating the opportunity with a social media listening program. For example, how active and engaged is this study community on social media? Or, how many Facebook groups, outlets, etc. are out there for these patients to find each other? Next, evaluate the outlet – What are all my options when building a social media page? Or, what outlets can I use if I just want to advertise?

FDA Proposes Social Media Guidelines. Sort of.

  
  
  
!Q6UJ9A01D69AICT Summer 2012 p24  (4) rev resized 600

A few weeks ago, and nearly five years after its open hearing on the topic, the Food and Drug Administration (FDA) finally released its proposed guidelines for how drug and device makers should navigate social media. Much has been written on the new guidelines including a few informative posts by Ed Silverman at the Wall Street Journal. As Silverman notes, among the 50 largest drug makers, half are still not using social media to engage consumers or patients, according to a survey by the IMS Institute for Health Informatics. He also suggests that the FDA will likely use the guidances as trial-and-error blueprints themselves as they run across questions that were not answered or situations that may not have been anticipated.

Meaningful Data Analysis and Adaptive Patient Recruitment Tactical Efficacy

  
  
  
describe the image

This is the second part of a two-part series by Joan F. Bachenheimer, founding principal, and Matt Kibby, principal, technology and innovation, BBK Worldwide.

Even if you were able to correlate advertising referrals to consented patients with a high degree of accuracy (and then to screen-fail and randomization) the fact of the matter is, "So what?"

Four scenarios spring to mind with regard to the quest for this correlation:

All Posts